Basilea Pharmaceutica AG (0QNA.L)
CHF 41.65
(-2.93%)
CHF 41.65
(-2.93%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 157.63 Million | 147.76 Million | 148.12 Million | 127.62 Million | 134.38 Million | 132.55 Million |
| Cost of Revenue | 26.79 Million | 26.8 Million | 24.07 Million | 24.05 Million | 18.86 Million | 125.24 Million |
| Gross Profit | 130.84 Million | 120.96 Million | 124.05 Million | 103.57 Million | 115.51 Million | 7.31 Million |
| Operating Expenses | 111.63 Million | 104.61 Million | 122.87 Million | 126.83 Million | 132.71 Million | 31.94 Million |
| Selling, General and Administrative Expenses | 33.78 Million | 30.81 Million | 29.72 Million | 29.42 Million | 30.05 Million | 30.47 Million |
| Research and Development Expenses | 77.85 Million | 73.8 Million | 93.15 Million | 97.41 Million | 102.66 Million | 105.14 Million |
| Other Expenses | - | 810 Thousand | -1.23 Million | - | - | 938 Thousand |
| Cost and Expenses | 138.42 Million | 131.42 Million | 146.95 Million | 150.88 Million | 151.58 Million | 157.18 Million |
| Operating Income | 19.2 Million | 16.34 Million | 1.17 Million | -23.25 Million | -17.2 Million | -23.15 Million |
| Interest Expense | 11.2 Million | 11.01 Million | 11.06 Million | 10.13 Million | 8.32 Million | 10.21 Million |
| Income Tax Expense | 10 Thousand | -45 Thousand | 37 Thousand | 55 Thousand | 40 Thousand | 192 Thousand |
| Earnings before Tax | 10.46 Million | 12.1 Million | -6.79 Million | -14.66 Million | -22.38 Million | -31.16 Million |
| Net Income | 10.45 Million | 12.14 Million | -6.83 Million | -14.72 Million | -22.42 Million | -31.35 Million |
| Earnings Per Share Basic | 0.87 | 1.02 | -0.58 | -1.43 | -2.08 | -2.89 |
| Earnings Per Share Diluted | 0.86 | 1.02 | -0.58 | -1.43 | -2.08 | -2.89 |
| Weighted Average Shares Outstanding | 11.99 Million | 11.86 Million | 11.68 Million | 10.28 Million | 10.75 Million | 10.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 12.14 Million | 11.94 Million | 11.68 Million | 10.28 Million | 10.75 Million | 10.83 Million |
| Gross Margin | 0.83 | 0.82 | 0.84 | 0.81 | 0.86 | 0.06 |
| EBIT Margin | 0.19 | 0.13 | 0.02 | -0.16 | -0.12 | -0.16 |
| Profit Margin | 0.07 | 0.08 | -0.05 | -0.12 | -0.17 | -0.24 |
| EBITDA | 29.49 Million | 26.21 Million | 6.72 Million | -2.23 Million | -14.12 Million | -22.75 Million |
| Earnings Before Tax Margin | 0.12 | 0.11 | 0.01 | -0.18 | -0.13 | -0.17 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 76.29 Million | 157.63 Million | 72.72 Million | 84.9 Million | 147.76 Million | 89.11 Million |
| Cost of Revenue | 51.71 Million | 26.79 Million | 16.79 Million | 9.99 Million | 26.8 Million | 9.68 Million |
| Gross Profit | 24.57 Million | 130.84 Million | 55.93 Million | 74.9 Million | 120.96 Million | 79.43 Million |
| Operating Expenses | 15.32 Million | 111.63 Million | 73.62 Million | 38.01 Million | 104.61 Million | 51.85 Million |
| Selling, General and Administrative Expenses | 15.06 Million | - | 17.23 Million | 16.54 Million | - | 15.19 Million |
| Research and Development Expenses | 33.59 Million | - | 56.38 Million | 21.46 Million | - | 36.65 Million |
| Other Expenses | -33.33 Million | -1.93 Million | - | - | 810 Thousand | - |
| Cost and Expenses | 67.03 Million | 138.42 Million | 90.42 Million | 48 Million | 131.42 Million | 61.53 Million |
| Operating Income | 9.25 Million | 19.2 Million | -17.69 Million | 36.89 Million | 16.34 Million | 27.58 Million |
| Interest Expense | - | 15.55 Million | 9.76 Million | 5.79 Million | 11.01 Million | 5.86 Million |
| Income Tax Expense | 13.41 Million | 10 Thousand | -17 Thousand | 27 Thousand | -45 Thousand | -33 Thousand |
| Earnings before Tax | 7.32 Million | 10.46 Million | -21.4 Million | 31.86 Million | 12.1 Million | 24.32 Million |
| Net Income | 20.73 Million | 10.45 Million | -21.38 Million | 31.84 Million | 12.14 Million | 24.35 Million |
| Earnings Per Share Basic | 1.72 | - | -1.78 | 2.66 | - | 2.04 |
| Earnings Per Share Diluted | 1.61 | - | -1.78 | 2.31 | - | 2.04 |
| Weighted Average Shares Outstanding | 12.85 Million | 11.99 Million | 12 Million | 11.97 Million | 11.86 Million | 11.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 13.82 Million | 12.14 Million | 12 Million | 13.78 Million | 11.94 Million | 11.95 Million |
| Gross Margin | 0.32 | 0.83 | 0.77 | 0.88 | 0.82 | 0.89 |
| EBIT Margin | 0.13 | - | -0.22 | 0.46 | - | 0.32 |
| Profit Margin | 0.27 | 0.07 | -0.29 | 0.38 | 0.08 | 0.27 |
| EBITDA | 10.15 Million | - | -15.96 Million | 38.65 Million | - | 28.32 Million |
| Earnings Before Tax Margin | 0.12 | 0.12 | -0.24 | 0.43 | 0.11 | 0.31 |
AMRQ
BETW
4667
000670
GLOSTERLTD
NOVAAGRI